Maha Rashtra Apex Corporation Limited has officially announced the detailed terms of its rights issue following the board meeting held on March 11, 2026. The company confirmed March 20, 2026, as the record date for determining eligible shareholders, in compliance with Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Board Meeting Outcome and Regulatory Compliance

The board of directors, in their meeting conducted from 12:30 PM to 5:00 PM on March 11, 2026, finalized the comprehensive rights issue structure. Company Secretary and Compliance Officer Jamsheed Minoo Panday communicated the outcome to both BSE Limited and National Stock Exchange of India Limited on the same day.

Rights Issue Structure and Financial Terms

The rights issue follows the in-principle approval received from National Stock Exchange of India Limited and BSE Limited dated March 05, 2026, and March 04, 2026, respectively. The offering provides existing shareholders with an opportunity to subscribe to additional equity shares at par value.

Implementation Timeline and Market Process

The company has established a detailed timeline for the rights issue implementation, providing shareholders with adequate time for participation and market renunciations. The rights entitlements will be credited in dematerialized form to eligible shareholders' demat accounts.

Share Capital Impact and Advisory Appointment

Upon completion assuming full subscription, the rights issue will increase the company's outstanding equity shares from 1,40,91,896 shares to 2,81,83,792 shares, maintaining the face value of Rs. 10 per share. T&S Law has been appointed as Advisor to the rights issue, with the Letter of Offer adopted by the board for filing with both stock exchanges.

Maha Rashtra Apex Corporation Limited has announced its board's approval for a rights issue to raise funds for business expansion. The company disclosed this development following a board meeting held on December 18, 2025, in compliance with SEBI listing regulations.

Rights Issue Details

The board approved raising funds through the issuance and allotment of equity shares with specific parameters:

The rights issue will be offered to eligible equity shareholders as on the record date, which will be notified subsequently. The issue is subject to receipt of regulatory and statutory approvals in accordance with the provisions of Section 62(1)(a) of the Companies Act, 2013, and applicable laws including SEBI regulations.

Board Meeting Proceedings

The board meeting commenced at 12:00 Noon and concluded at 3:00 PM on December 18, 2025. The board approved several key decisions beyond the rights issue:

The Rights Issue Committee will have the authority to determine the final terms and conditions of the issue at a later date, providing flexibility in execution based on market conditions and regulatory requirements.

Regulatory Compliance and Documentation

The company has ensured full compliance with regulatory requirements for this announcement. The disclosure was made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company secretary and compliance officer, Jamsheed M Panday, signed the official communication to stock exchanges.

Market Communication

The company has informed both major stock exchanges about this development:

This rights issue represents Maha Rashtra Apex Corporation's move to strengthen its capital base and fund future growth initiatives. The company will provide further details about the record date, issue timeline, and specific terms once the Rights Issue Committee finalizes the arrangements and receives necessary regulatory approvals.